Related Experiment Video

Updated: Nov 24, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K

Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases

Hai-Yan Xu1, Yong-Ju Yu2, Qian-Hui Zhang3

  • 1Department of Military Psychology, School of Psychology, Army Medical University, Chongqing, China.

Frontiers in Pharmacology
|December 28, 2020
PubMed

Insights

Improving cardiovascular disease (CVD) medication adherence requires tailored interventions. This review examines recent strategies for identifying nonadherence and overcoming barriers to enhance patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) research has advanced significantly, yet medication adherence remains a major challenge.
  • Approximately 50% of patients do not adhere to prescribed medications, leading to poor therapeutic effects, adverse outcomes, and increased healthcare costs.
  • Existing medication adherence interventions show limited success, highlighting the need for personalized approaches.

Purpose of the Study:

  • To review and synthesize the literature on tailored interventions for improving medication adherence in cardiovascular disease (CVD) patients over the last five years.
  • To identify current challenges and propose future directions for tailored adherence strategies in CVD management.
  • To re-evaluate methods for enhancing medication adherence in CVD.

Main Methods:

  • Systematic literature review of studies published within the last five years focusing on tailored interventions for CVD medication adherence.
  • Analysis of research addressing patient identification, adherence barrier detection, intervention delivery, and theoretical frameworks.
  • Synthesis of findings to assess the current state and future potential of tailored adherence interventions.

Main Results:

  • Tailored interventions are proposed as a promising strategy to address the limitations of current adherence programs.
  • Key areas for tailored interventions include identifying nonadherent patients, understanding individual barriers, and implementing customized clinical support.
  • The review identifies current difficulties in implementing and scaling tailored interventions.

Conclusions:

  • Tailored interventions represent a critical avenue for improving medication adherence in cardiovascular disease (CVD).
  • Further research is needed to refine methods for patient stratification, barrier assessment, and personalized intervention delivery.
  • Addressing current implementation challenges is essential for the successful integration of tailored adherence strategies into routine CVD care.

Keywords:
barriers to medication adherencecardiovascular diseasemedication adherencemedication adherence interventionstailored interventions

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.7K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
149
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
127
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
119
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
94
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
313
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
98